Advertisement
VideoWired
VIDEO SEARCH
SPONSORED LINKS
Advertisement
Advertisement
VIDEO RESULTS
ProfEdisonLiuGenomeInstituteofSingapore
From: www.ecancer.tv on Tue, Dec 28 2010 7:32 AM
Cancer is a complex disease which is caused by multiple genetic and epigenetic changes. In addition, cancer is a genetic moving target capable of mutating into resistant or more aggressive forms. Prof Liu’s team have employed a strategy of using genomic data to reconstruct systems maps of critic...
0 of 5 Stars
ProfPatrickJohnstonQueensUniversityBelfastUK
From: www.ecancer.tv on Tue, Dec 28 2010 7:32 AM
Since 1996 Prof Patrick Johnston has led the development of the Belfast City Hospital Cancer Centre and has built up this centre to the point where it now carries out a substantial number of clinical trials, takes part in international research and in 2006 opened the centre for cancer research a...
0 of 5 Stars
ClaudiaMcVieTenovusCardiffUK
From: www.ecancer.tv on Tue, Dec 28 2010 6:31 AM
Claudia McVie talks about the history of Tenovus and the work that the organisation has done to aid the fight against cancer. The early work of Tennovus included funding research on drugs such as tamoxifen, establishing specialist oncology nurses and developing a support line for cancer patients...
0 of 5 Stars
DrIanLewisTenovusCardiffUK
From: www.ecancer.tv on Tue, Dec 28 2010 6:31 AM
Dr Ian Lewis, research manger at Tenovus, talks about the 'Sing for Life' choir that will be opening the 2010 NCRI meeting. This choir, made up of cancer patients, survivors, carers and family, was set up to provide an alternative form of support group for cancer patients but has also ...
0 of 5 Stars
AlojzPeterleMemberoftheEuropeanParliament
From: www.ecancer.tv on Tue, Dec 21 2010 9:32 AM
Alojz Peterle - Member of the European Parliament for Slovenia discusses how the current European health and research policy environment creates opportunities for innovation and creativity in oncopolicy, and the role of the European Parliament in cancer control. Speaking at the Oncopolicy Forum ...
0 of 5 Stars
DrGillesVassalInstitutGustaveRoussyParisFrance
From: www.ecancer.tv on Tue, Dec 21 2010 9:32 AM
An expert on the European network of cancer research in children and adolescents speaks to ecancer reporter Peter Goodwin about paedeatric cancer care across Europe including the work of SIOPE (Société Internationale d’Oncologie Pédiatrique Europe). Talking at the Oncopolicy Forum, 26th October ...
0 of 5 Stars
DrAndreasUllrichWorldHealthOrganisationMedicalOfficer
From: www.ecancer.tv on Tue, Dec 21 2010 9:31 AM
Role of WHO in cancer prevention and control (National Cancer Plans). Speaking at the Oncopolicy Forum 26th October 2010, Brussels.
0 of 5 Stars
TomHudsonPresidentofEuropeanCancerPatientCoalition
From: www.ecancer.tv on Tue, Dec 21 2010 9:31 AM
European Cancer Patient Coalition President Tom Hudson talks to ecancer about the patient role in informing EU policy on cancer. Speaking at the Oncopolicy Forum, 26th October 2010, Brussels.
0 of 5 Stars
DrMarijaSeljakDirectoroftheSlovenianNationalInstituteOfPublicHealth
From: www.ecancer.tv on Tue, Dec 21 2010 9:31 AM
Dr Marija Seljak, Director of the Slovenian National Institute Of Public Health, talks to ecancer reporter Peter Goodwin at the Oncopolicy Forum, European Economic and Social Committee (EESC) ,Brussels, Belgium, 26th October 2010: Role of Member States in the fight against cancer and Slovenia’s ...
0 of 5 Stars
ProfAlexanderEggermontandProfAntonBerns
From: www.ecancer.tv on Tue, Dec 21 2010 9:31 AM
Prof Alexander Eggermont , President of the European Academy of Cancer Sciences and Prof Anton Burns, Fellow of the European Academy of Cancer Sciences discuss the organisation’s role: Uniqueness of the Academy in proving high-level evidenced based scientific advice and relation with the Europea...
0 of 5 Stars
DrAndrzejRyPublicHealthandRiskAssessmentDirectorEuropeanCommission
From: www.ecancer.tv on Tue, Dec 21 2010 9:31 AM
Dr Andrzej Ryś discusses EU Commission commitment to the fight against cancer and the role of the European level in non-communicable chronic diseases. Speaking at the Oncopolicy Forum 26th October 2010, Brussels.
0 of 5 Stars
IngridKsslerEuropeanEconomicandSocialCommittee
From: www.ecancer.tv on Tue, Dec 21 2010 9:31 AM
Ingrid Kössler of the European Economic and Social Committee, talks about the organisation’s role in tackling European health and cancer inequalities. Speaking at the Oncopolicy Forum 26th October 2010, Brussels.
0 of 5 Stars
DrDouglasLevineMemorialSloanKetteringCancerCenter
From: www.ecancer.tv on Tue, Dec 07 2010 11:43 AM
Dr Douglas Levine talks about the Cancer Genome Atlas, a collaborative project between the National Cancer Institute and the National Human Genome Research Institute. This project was designed to catalogue all the genomic changes in glioblastoma, ovarian cancer and lung squamous carcinoma. Dr Le...
0 of 5 Stars
ProfNicolettaColomboEuropeanInstituteofMilanItaly
From: www.ecancer.tv on Tue, Dec 07 2010 11:43 AM
Prof Nicoletta Colombo speaks to ecancer.tv about trabectedin, a drug that has recently been approved for use with pegylated liposomal doxorubicin to treat partially platinum sensitive recurrent ovarian cancer patients. This treatment successfully increases the platinum free interval in partiall...
0 of 5 Stars
DrMuratGultekinCankiriDevletHospitalCankiriTurkeyDrBorisVranesInstituteOfGynecologyAndObstetricsBelgradeSerbia
From: www.ecancer.tv on Tue, Dec 07 2010 11:43 AM
Dr Murat Gultekin and Dr Boris Vranes the president elect and current president of the European Network of Young Gynae Oncologists (ENYGO) speak to ecancer.tv about this society for young gynecologic oncologists. ENYGO was set up to encourage networking and collaborations between young gynecologi...
0 of 5 Stars
DrLucasMinigHospitalUniversitarioMadridSanchinarroSpain
From: www.ecancer.tv on Tue, Dec 07 2010 11:43 AM
Dr Lucas Minig discusses a pilot study investigating the use of an inter-uterine devise (IUD) to treat young women with atypical endometrial hyperplasia (AEH) or early endometrial cancer limited to the endometrium. The Mirena IUD is a coil that releases a low dose of the progesterone hormone levo...
0 of 5 Stars
ProfChristianMarthInnsbruckMedicalUniversityAustria
From: www.ecancer.tv on Tue, Dec 07 2010 11:43 AM
Professor Christian Marth discusses whether clinicians should continue to follow-up ovarian cancer patients using the CA-125 tumour marker. A recent study has shown that early treatment in response to a rise in this tumour marker does not increase patient survival; however the patients in this st...
0 of 5 Stars
JanGeisslerDrStephenOBrienJanaPelouchovDrAndrasFehervary
From: www.ecancer.tv on Fri, Dec 03 2010 5:22 AM
In this second part of the questions from members of the audience at the EHA patient advocacy session on 'access to clinical trials', the panel consider the need for independent organisations to decide the direction of clinical studies; the value of multidiscipline dialogue between pat...
0 of 5 Stars
JanaPelouchovDiagnozaCMLPragueCzechRepublic
From: www.ecancer.tv on Fri, Dec 03 2010 5:22 AM
Jana Pelouchová director of the Czech CML patient group "Diagnoza CML" discusses some of the barriers to patient participation in clinical trials and offers the patients perspective on these issues. Access to information, informed consent, mobility issues, travel expenses and language barriers a...
0 of 5 Stars
JanGeisslerLeukmieOnlineeVGermany
From: www.ecancer.tv on Fri, Dec 03 2010 5:22 AM
Clinical trials are a key step in the process of developing and improving treatment - and finding cures - for cancer. Patients with resistant or recurrent disease often seek out these trials as a means to stay alive. Furthermore, late phase observational trials are crucial to improve the evidenc...
0 of 5 Stars

VIDEOWIRED.COM FEATURED